Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic

Background: Vitamin K antagonists have been the treatment of choice in preventing thromboembolic events, but problems such as frequent dose adjustment and monitoring of coagulation status, including multiple drug and food interactions, make their use difficult. Dabigatran etexilate is a new oral dir...

Full description

Saved in:
Bibliographic Details
Main Authors: Donaldson M, Norbeck AO
Format: Artigo
Language:Inglês
Published: Centro de Investigaciones y Publicaciones Farmaceuticas 2013-06-01
Series:Pharmacy Practice
Subjects:
Antithrombins
Benzimidazoles
Warfarin
Drug Toxicity
United States
Online Access:http://www.pharmacypractice.org/journal/index.php/pp/article/view/340
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items